Home : Corporate Info : International

International CRO Services

ABR is a full-service, Phase I-IV global CRO dedicated to meeting the needs of pharmaceutical, biotechnology, and medical device companies. ABR manages and monitors international Phase II‑IV clinical trials from it’s North American offices and from affiliated European offices in the United Kingdom, France and Germany. ABR plans to expand it’s regional CRO offices in Central and Eastern Europe, India and China within the next year.

ABR offers an extensive range of international clinical services including clinical study design, strategic and regulatory consulting, project management, monitoring, clinical data management, biostatistics, pharmacokinetic and pharmacodynamic analysis, quality assurance auditing, medical writing, pharmacovigilance and regulatory submissions.

ABR’s clinical research professionals have a successful track record of executing and managing Phase II-IV multicenter trials in North America, Europe and Asia, and our accomplished team has been involved in more than 400 clinical trials since 1994.

ABR’s dedicated staff employ the latest information technology to perform, manage and monitor clinical trials in a cost-efficient and rapid manner, including using a web-based, secure ABR Study Tracker™, which is a sophisticated study and document management tool. ABR also provides pharmacovigilance services with dedicated medical and clinical safety staff and employing it’s e‑Vigilance™ software application, which is a pharmacovigilance tool capable of submitting suspected unexpected serious adverse reactions (SUSARs) for Eudravigilance and MedWatch adverse event reporting.

ABR also provides sophisticated clinical data management services using Oracle Clinical™ (Oracle Corporation) and web-based Electronic Data Capture (EDC) software applications.